Trip Therapeutics announced On Wednesday, the company announced that it had submitted an investigational new drug (IND) to the U.S. Food and Drug Administration (FDA) for a Phase 2a clinical trial that will investigate the effects of psilocybin-assisted psychotherapy in treating patients over the age of 21 who suffer from: ) has submitted an application.”
The post Biotech Company Seeks FDA Approval For Psilocybin-IBS Treatment appeared first on Cannabis News | NUG Magazine.
Trip Therapeutics announced On Wednesday, the company announced that it had submitted an investigational new drug (IND) to the U.S. Food and Drug Administration (FDA) for a Phase 2a clinical trial that will investigate the effects of psilocybin-assisted psychotherapy in treating patients over the age of 21 who suffer from: ) has submitted an application.” […]
The post Biotech Company Seeks FDA Approval For Psilocybin-IBS Treatment appeared first on Cannabis News | NUG Magazine.
Cannabis News | NUG Magazine
You must log in to post a comment.